Pancreatic Cancer Research

ResearcherUniversity of PittsburghNo recent work listed

David Jérémie Birnbaum

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9026-3044; OpenAlex author ID A5101724462. Sources: OpenAlex.

Their work

Papers
15 (first author 2, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
34
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: 2 papers · 2017: 2 papers · 2018: 1 paper · 2019: 1 paper · 2020: 4 papers · 2021: 2 papers · 2022: 1 paper

Papers 15

  1. A Lesson in Transcriptional Plasticity: Classical Identity Is Silenced, but Not Lost, in Pancreatic Ductal Adenocarcinoma Cell Lines. Co-author DOI 10.1053/j.gastro.2022.07.005↗
  2. Intra-pancreatic distal cholangiocarcinoma and pancreatic ductal adenocarcinoma: a common short and long-term prognosis? Last author DOI 10.1007/s13304-021-00981-0↗
  3. Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-20-1039↗
  4. Prognostic impact of tumour-infiltrating lymphocytes and cancer-associated fibroblasts in patients with pancreatic adenocarcinoma of the body and tail undergoi… Last author DOI 10.1002/bjs.11434↗
  5. Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer-Letter. Co-author DOI 10.1158/1078-0432.ccr-20-1969↗
  6. Neoplastic-Stromal Cell Cross-talk Regulates Matrisome Expression in Pancreatic Cancer. Co-author DOI 10.1158/1541-7786.mcr-20-0439↗
  7. FOLFIRINOX Versus Gemcitabine-based Therapy for Pancreatic Ductal Adenocarcinoma: Lessons from Patient-derived Cell Lines. First author DOI 10.21873/anticanres.14355↗
  8. XPO1 Expression Is a Poor-Prognosis Marker in Pancreatic Adenocarcinoma. Co-author DOI 10.3390/jcm8050596↗
  9. Molecular classification as prognostic factor and guide for treatment decision of pancreatic cancer. Co-author DOI 10.1016/j.bbcan.2018.02.001↗
  10. Prognostic Value of Molecular Subtypes in Pancreatic Cancer. First author DOI 10.1097/mpa.0000000000000787↗
  11. A 25-gene classifier predicts overall survival in resectable pancreatic cancer. Co-author DOI 10.1186/s12916-017-0936-z↗
  12. Prognostic value of PDL1 expression in pancreatic cancer. Co-author DOI 10.18632/oncotarget.11685↗
  13. Expression of Genes with Copy Number Alterations and Survival of Patients with Pancreatic Adenocarcinoma. Co-author PMID 27107061↗
  14. The emerging role of the TGFβ tumor suppressor pathway in pancreatic cancer. Co-author DOI 10.4161/cc.11.4.19130↗
  15. Genome profiling of pancreatic adenocarcinoma. Co-author DOI 10.1002/gcc.20870↗

Closest collaborators

The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. François Bertucci · 10 shared papers, 2016–2022 · strength 0.99
  2. Daniel Birnbaum · 11 shared papers, 2011–2021 · strength 0.90
  3. Émilie Mamessier · 9 shared papers, 2011–2020 · strength 0.66
  4. Andrew Louis Warshaw · 4 shared papers, 2020–2022 · strength 0.46
  5. Andrew Scott Liss · 4 shared papers, 2020–2022 · strength 0.46
  6. Keith D. Lillemoe · 4 shared papers, 2020–2022 · strength 0.46
  7. Carlos F. Fernandez-del Castillo · 3 shared papers, 2020–2021 · strength 0.29
  8. Sebastian K.S. Begg · 3 shared papers, 2020–2021 · strength 0.29
  9. Mari A. Mino-Kenudson · 3 shared papers, 2020–2021 · strength 0.29
  10. Jean‐Luc Raoul · 4 shared papers, 2016–2017 · strength 0.24
  11. Théophile Guilbaud · 2 shared papers, 2020–2021 · strength 0.24
  12. Jean‐Robert Delpéro · 4 shared papers, 2011–2017 · strength 0.19
  13. Flora Poizat · 3 shared papers, 2016–2017 · strength 0.19
  14. Marine Gilabert · 3 shared papers, 2016–2017 · strength 0.19
  15. Ulrich Friedrich Wellner · 2 shared papers, 2020 · strength 0.19
  16. Oliver Schilling · 2 shared papers, 2020 · strength 0.19
  17. David Tsai Ting · 2 shared papers, 2020–2021 · strength 0.19
  18. Thomas P. Hank · 2 shared papers, 2020–2021 · strength 0.19
  19. Carlos Fernández-del Castillo · 1 shared paper, 2022 · strength 0.16
  20. Taisuke Baba · 1 shared paper, 2022 · strength 0.16
  21. Olivıer Turrini · 3 shared papers, 2011–2016 · strength 0.13
  22. Mircea Chirica · 1 shared paper, 2021 · strength 0.13
  23. Thomas Delayre · 1 shared paper, 2020 · strength 0.11
  24. Azfar Neyaz · 1 shared paper, 2021 · strength 0.11
  25. Vikram Deshpande · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.